Search
30 results
-
Parkinson's disease can redirect a disease-relevant process. The original
matched in: search_vector
-
Parkinson's disease can redirect a disease-relevant process. The original
matched in: search_vector
- Hypothesis Age-Accelerated miR-155 Upregulation Primes Nigral Microglia for Parkinson's Disease Pathology
Parkinson's Disease Pathology starts from the claim that modulating
matched in: search_vector
-
Parkinson's Disease Models starts from the claim that modulating
matched in: search_vector
- Hypothesis TFEB Activation to Restore Lysosomal Function in Parkinson's Disease Alpha-Synuclein Clearance
Parkinson's disease is characterized by the accumulation of misfolded
matched in: search_vector
-
Parkinson's disease show elevated CSF levels of LC3-II and p62, indicating
matched in: search_vector
- Hypothesis TFEB Activation to Restore Lysosomal Biogenesis in Parkinson's Disease Dopaminergic Networks
Parkinson's disease, particularly alpha-synuclein oligomers and Lewy bodies
matched in: search_vector
- Hypothesis Hsp70-based therapy to prevent lysosomal membrane permeabilization and cathepsin release in AD
Parkinson's disease. [PMID:25888784]. 3. Hsp70 levels decline with
matched in: search_vector
-
Parkinson's disease), cortical and hippocampal neurons in Alzheimer's disease
matched in: search_vector
-
Parkinson's disease, Huntington's disease, and ALS, GAPDH aggregation
matched in: search_vector
-
Parkinson's disease, not AD; mechanistic translatability unclear. Identifier N/A. 2. Retromer
matched in: search_vector
-
Parkinson's disease models. [PMID:38013355]. 3. Serum GDF15 correlates
matched in: search_vector
-
Parkinson's disease models provide particularly compelling evidence for TFEB/TFE3
matched in: search_vector
-
Parkinson's disease cases, identifies patients most likely to benefit
matched in: search_vector
-
Parkinson's disease by decades. ## **Preclinical Evidence** Multiple animal models
matched in: search_vector
-
Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Preclinical
matched in: search_vector
-
Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis, where
matched in: search_vector
-
Parkinson's disease and self-reported sleep-related traits implicates
matched in: search_vector
-
Parkinson's disease model demonstrate that NLRP3 deficiency provides neuroprotection
matched in: search_vector
-
The eukaryotic initiation factor 2α (eIF2α) phosphorylation pathway critically regulates
matched in: search_vector
-
Parkinson's disease and self-reported sleep-related traits implicates
matched in: search_vector
-
Parkinson's disease, different epigenetic clock algorithms (Horvath, Hannum, PhenoAge
matched in: search_vector
-
Parkinson's disease, and amyotrophic lateral sclerosis through defective clearance
matched in: search_vector
-
Parkinson's disease (PD), the progressive depletion of butyrate-producing
matched in: search_vector
-
Parkinson's disease, Huntington's disease, and ALS. Disease-specific
matched in: search_vector
-
Parkinson's Disease Rating Scale Part III shows significantly reduced
matched in: search_vector
-
Parkinson's disease models, where normalized eIF2α signaling promotes clearance
matched in: search_vector
-
Parkinson's disease. Combination approaches integrate small molecule therapy with
matched in: search_vector
-
Parkinson's, and Huntington's disease, the accumulation of misfolded
matched in: search_vector
-
Parkinson's disease, and Alzheimer's disease models, IGFBPL1 overexpression
matched in: search_vector